190 related articles for article (PubMed ID: 7516852)
1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.
Balani SK; Pitzenberger SM; Kauffman LR; Arison BH; Ramjit HG; Goldman ME; O'Brien JA; King JD; Hoffman JM; Rooney CS
Drug Metab Dispos; 1992; 20(6):869-76. PubMed ID: 1283569
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
Prueksaritanont T; Dwyer LM; Balani SK; Theoharides AD
Drug Metab Dispos; 1994; 22(2):281-8. PubMed ID: 7516854
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
Balani SK; Goldman ME; Kauffman LR; Varga SL; O'Brien JA; Smith SJ; Olah TV; Ramjit HG; Schorn TW; Pitzenberger SM
Drug Metab Dispos; 1993; 21(4):598-604. PubMed ID: 7690697
[TBL] [Abstract][Full Text] [Related]
5. Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.
Balani SK; Arison BH; Mathai L; Kauffman LR; Miller RR; Stearns RA; Chen IW; Lin JH
Drug Metab Dispos; 1995 Feb; 23(2):266-70. PubMed ID: 7736923
[TBL] [Abstract][Full Text] [Related]
6. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
Chang M; Sood VK; Kloosterman DA; Hauer MJ; Fagerness PE; Sanders PE; Vrbanac JJ
Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
8. Human pharmacokinetics and tolerability of L-697,639, a non-nucleoside HIV-1 reverse transcriptase inhibitor.
Van Hecken A; Depre M; De Lepeleire I; Laskin O; Au T; Woolf E; Yeh KC; De Schepper PJ
Int J Clin Pharmacol Res; 1994; 14(2):45-50. PubMed ID: 7530697
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Zhang W; Branstetter DG
Drug Metab Dispos; 1997 Jul; 25(7):828-39. PubMed ID: 9224777
[TBL] [Abstract][Full Text] [Related]
10. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.
Balani SK; Pitzenberger SM; Schwartz MS; Ramjit HG; Thompson WJ
Drug Metab Dispos; 1995 Feb; 23(2):185-9. PubMed ID: 7736909
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of pravastatin sodium in humans.
Everett DW; Chando TJ; Didonato GC; Singhvi SM; Pan HY; Weinstein SH
Drug Metab Dispos; 1991; 19(4):740-8. PubMed ID: 1680649
[TBL] [Abstract][Full Text] [Related]
14. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
Potts W; van Horn R; Anderson K; Blake T; Garver E; Joseph G; Dreyer G; Shu A; Heys R; Fong KL
Drug Metab Dispos; 1995 Aug; 23(8):799-805. PubMed ID: 7493545
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
[TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism, and excretion of atevirdine in the rat.
Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Schuette MR; Judy RW; Voorman RL; Maio SM; Slatter JG
Drug Metab Dispos; 1998 Oct; 26(10):1008-18. PubMed ID: 9763407
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK3530) in rats.
Lee J; Yoo HH; Rhim KJ; Sohn DR; Kim DH
Rapid Commun Mass Spectrom; 2007; 21(7):1139-49. PubMed ID: 17318927
[TBL] [Abstract][Full Text] [Related]
20. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.
Prueksaritanont T; Balani SK; Dwyer LM; Ellis JD; Kauffman LR; Varga SL; Pitzenberger SM; Theoharides AD
Drug Metab Dispos; 1995 Jul; 23(7):688-95. PubMed ID: 7587955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
